What is the recommended dosage of acyclovir (antiviral medication) for children with varicella (chickenpox)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosage for Children with Varicella

For children with chickenpox, the recommended oral acyclovir dose is 20 mg/kg (maximum 800 mg) four times daily for 5 days, initiated within 24 hours of rash onset. 1

Standard Treatment Dosing

  • Children 2 years and older: 20 mg/kg per dose orally 4 times daily (total 80 mg/kg/day) for 5 days 1
  • Children over 40 kg: 800 mg orally 4 times daily for 5 days (adult dose) 1
  • Timing is critical: Treatment should be initiated within 24 hours of rash onset for maximum efficacy 1, 2

Immunocompromised Children

For HIV-infected or immunocompromised children with varicella, the dosing differs based on disease severity:

  • Mild disease (no or moderate immunosuppression): 20 mg/kg orally (maximum 800 mg/dose) 4 times daily for 7-10 days or until no new lesions for 48 hours 3
  • Severe immunosuppression: 10 mg/kg IV every 8 hours for 7-10 days, followed by oral therapy 3
  • Some experts recommend dosing based on body surface area (500 mg/m²/dose IV every 8 hours) for children over 1 year 3

Clinical Efficacy and Considerations

When started within 24 hours of rash, acyclovir treatment provides:

  • Fewer total lesions (294 vs 347 in placebo) 2
  • Cessation of new lesion formation by day 3 in over 95% of patients 2
  • Reduced duration of fever and constitutional symptoms to 3-4 days 2
  • Less itching and faster progression to crusted/healed stages 2

Important caveat: The American Academy of Pediatrics does not recommend routine acyclovir for all healthy children with chickenpox, as the clinical benefit may not justify routine use 3. However, acyclovir should be considered for:

  • Children ≥12 years of age 3, 4
  • Those with chronic cutaneous or pulmonary disorders 3, 4
  • Children receiving long-term salicylate therapy 3
  • Secondary household cases (per some experts) 3

Renal Dosing Adjustments

For children with renal impairment, dose modifications are necessary 1:

  • Creatinine clearance 10-25 mL/min/1.73m²: 800 mg every 8 hours
  • Creatinine clearance 0-10 mL/min/1.73m²: 800 mg every 12 hours
  • Hemodialysis patients: Administer additional dose after each dialysis 1

Alternative Formulations

  • Valacyclovir (acyclovir prodrug) can be used in children ≥2 years: 20 mg/kg three times daily for 5 days for varicella-zoster infections 5
  • Valacyclovir provides enhanced bioavailability compared to oral acyclovir 5
  • No pediatric formulation of famciclovir is available 3

Safety Profile

  • Acyclovir is well-tolerated in children 2
  • Does not interfere with antibody development or immune response 3, 4
  • Does not alter future herpes zoster risk 4
  • Mild, self-limiting diarrhea may occur in some patients 6

References

Research

A controlled trial of acyclovir for chickenpox in normal children.

The New England journal of medicine, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acyclovir Treatment for Chickenpox and Herpes Zoster Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.